Diabetes: Screening Tool and Prevalence

Epidemiology (Diabetes)
Student’s Name
Professor’s Name
Institutional Affiliations
Course Name and Number
Due Date
Epidemiology (Diabetes)
Diabetes is one of the leading causes of global morbidity and mortality. Saeedi et al. (2019) report that the disease constitutes the ten primary causes of adult deaths, contributing to approximately 4 million deaths worldwide in 2017. Its impacts percolate to other healthcare aspects, including stretching the workforce due to the demand for care and raising health-related expenses. As a result, physicians should routinely screen susceptible individuals for timely care and curb the prevalence of the illness.
Different factors cause the emergence of diabetes. According to CDC (2022), these elements vary depending on the type of diabetes. For instance, type 1 arises from age and genetic-related causes. Type 2 can develop due to lifestyle issues, including advancing age, increased body weight, poor diet, physical inactivity, genetics, pregnancy, and many other risks. These aspects illustrate that diabetes is a complex disease that can develop due to various factors.
Data estimates and projections indicate that diabetes has become a critical issue of healthcare concern. For instance, Saeedi et al. (2019) reveal that about 463 million individuals aged 20 to 79 were suffering from this disease by 2019. This population makes up approximately 9.3% of the adult globally. These figures represent an increase of about 62% in the last decade. Saeedi et al. (2019) indicate that the number of people with diabetes rose from 2285 to 463 million from 2009 to 2019. Such a consistent rise in the prevalence rate demonstrates the threats of the disease at the global level. Researchers reveal that statistics are worrying because projections confirm that about 50.1% of the people with this illness remain unaware because of a lack of screening. Thus, the reported figures might be conservative rather than a true illustration of the prevalence.
The many people living with this disease demonstrate the importance of healthcare institutions and other stakeholders conducting widespread screening for proper estimation and determination of intervention techniques. According to Saeedi et al. (2019), predictions reveal that by 2030, the prevalence rate may rise to 10.2% of persons aged 20-79, shifting from the 463 recorded in 2019 to 578 million individuals. Further estimates warn that this rate may rise to 700 million persons by 2045. In response to thi...